Image Description
Salim Moussa

Salim Moussa

Assistant professor

About


Full-time Faculty Member at the Medical Laboratory Technology Department-Beirut Arab University, 2017-present

Part-time Faculty Member at the Natural Sciences Department-Lebanese American University, 2015-2016.

Postdoc-Lebanese American University, 2015-2016.

University Diploma, Clinical Research-Faculty of Medicine, Montpellier-France, 2014

PhD in Bio-Health-University of Montpellier-France, 2013

Lecturer-University of Montpellier-France, 2011

Master degree in Bio-Health-University of Montpellier-France, 2009

ORCID: 0000-0002-2931-2679/ SCOPUS ID:57202378400

Full-time Faculty Member at the Medical Laboratory Technology Department-Beirut Arab University, 2017-present

Part-time Faculty Member at the Natural Sciences Department-Lebanese American University, 2015-2016.

Postdoc-Lebanese American University, 2015-2016.

University Diploma, Clinical Research-Faculty of Medicine, Montpellier-France, 2014

PhD in Bio-Health-University of Montpellier-France, 2013

Lecturer-University of Montpellier-France, 2011

Master degree in Bio-Health-University of Montpellier-France, 2009

ORCID: 0000-0002-2931-2679/ SCOPUS ID:57202378400

Undergraduate courses

Clinical serology and immunology (3 Crs.)

Cancer biology (3 Crs.)

Histopathology (3 Crs.)

Neurophysiology (2 Crs.)

Human anatomy and physiology (3 Crs.)

Human anatomy and physiology for nurses (3 Crs.)

Basic biology (3 Crs.)

Physiology (3 Crs.)

Histology (1 Cr.)

Clinical seminars (1 Cr.)

Graduate courses

Advanced Clinical Laboratory Immunology (3 Crs.)

Research Methodology (3 Crs.)

Applications of Pharmacogenomics in Cancer (3 Crs.)

Alayssami, H., Hachim, M. Y., Senok, A., & Moussa, S. (2026). Sodium Butyrate Activity in Colorectal Cancer under Hypoxia: A Potential Role for Carbonic Anhydrase IX. Asian Pacific journal of cancer prevention : APJCP, 27(6), 2219–2224. 

Zeineh, F., and Moussa, S. (2025). Awareness towards Cancer Attributable to Infections (CAI): A Lebanese study with a special focus on young adults, and adults. J. Prev. Med. Hyg. 66.

Reem El Hindi and Salim Moussa. Assessing the use of anti-PD-1/PD-L1 cancer therapies in the Middle-Eastern Country of Lebanon: a single-center study. Gulf Journal of Oncology. Issue 50, 2026

Moussa S. Cancer Stem Cell and Tumor Immune Microenvironment (TIME): Dangerous Crosstalk. Curr Mol Med. 2025 Jan 7. Vol. 25, No. 10, 2025.

Baalbaki, J., Agha, M., Jaafar, N., Yamout, B., & Moussa, S. Autoantibodies, clinical phenotypes and quality of life in Lebanese patients with myasthenia gravis. Intractable and Rare Diseases Research. 2023-Vol 12-Issue.2.

Mortada M and Moussa S. Assessment of nurses’ knowledge and care practices for infection prevention in neutropenic patients in Bekaa, Lebanon: A descriptive cross-sectional design. BAU Journal - Health and Wellbeing. 2021-Vol 4-Issue.1.

Saad N, Moussa S. Immune response to COVID-19 infection: a double-edged sword. Immunol Med. 2021 Jan 14:1-10.

Moussa S, Saleh F, El Shamieh S, Assi T, Othman A, Farhat F. Detection of PIK3R1 (L449S) Mutation in a Patient with Ovarian Cancer: A Case Report. Case Rep Oncol. 2020 Feb 20;13(1):188-192. 

Tfaily M and Moussa S. Assessment of healthcare waste management in hospitals of South Lebanon. BAU Journal - Health and Wellbeing. 2020; Vol. 2: Iss. 2, Article 9.

Assaf I and Moussa S. Effectiveness of a health education intervention about influenza and vaccine in secondary schools in South Lebanon. BAU Journal - Health and Wellbeing.2020. Vol. 2: Iss. 2, Article 7.

El Shamieh, S., Saleh, F., Moussa, S., Kattan, J., and Farhat, F. (2018). RICTOR gene amplification is correlated with metastasis and therapeutic resistance in triple-negative breast cancer. Pharmacogenomics 19, 757–760.

Research focus is Cancer Immunology.

IRB General Secretary and Voting Member

French Society for cancer immunotehrapy (FITC) Member

Founder and organizer of the annual international research meeting: Cancer and Immunity since 2022

LMS expert (Moodle, Coursera, CITI program, etc.)

Biorisk management and shipping of infectious substances